Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Research and Innovation Action · Running

TARGET Health virtual twins for the personalised management of stroke related to atrial fibrillation

Coordinator
Lunds Universitet, Sweden
Runs
1 January 2024 to 31 December 2028
Status
Running
EU funding
€7.0m
Total cost
€7.0m
Partners
20 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101136244

What the project is doing

In the project's own words, from its summary on CORDIS.

Atrial fibrillation (AF) is the most common heart arrhythmia worldwide, leading to life-limiting complications, high financial burden and significant resource utilisation. In Europe, stroke as a debilitating complication of AF, is amongst the commonest causes of death and the leading cause of disability. AF patients have a 5-fold increased risk for ischaemic stroke. Functional recovery from AF-related stroke (AFRS) is often unsatisfactory, leading to severe disability, reduced quality of life and high mortality.

TARGET’s ambition is to develop novel personalised, integrated, multi-scale computational models (virtual twins) and decision-support tools for the AF-related stroke pathway, starting from the healthy state, pathophysiology and disease onset, progression, treatment and recovery. TARGET aims to help prevent AF and AFRS, optimise acute management and rehabilitation, reduce long-term disability, provide a better quality of life for patients and caregivers, and lower healthcare costs.

We will ensure patients are at the heart of the project, and the association with experienced commercial partners will ensure the swift adoption of TARGET’s novel technologies. New observational data will be collected via 4 carefully designed prospective clinical studies, which will be used to test and validate the personalised tools and the virtual twin models using a clinical trial simulation (virtual/in-silico), to demonstrate evidence of clinically meaningful results.

TARGET will also help consolidate existing mechanistic virtual twin models of the heart, the brain and the neuromusculoskeletal system, enriching these twins to deliver more complex tasks, and supporting research to move towards a more integrated human virtual twin. TARGET represents a milestone project to improve the care and rehabilitation of patients with AF and AFRS, introducing a paradigm shift in risk prediction, diagnosis and management of the disease, and accelerating translational research into practice.

Topics

Who is involved

OrganisationCityCountryRole
Lunds UniversitetLundSwedenCoordinator
Technische Universitaet WienWienAustriaParticipant
Moverim SRLBruxelles / BrusselBelgiumParticipant
Revalidatieziekenhuis Inkendaal-Koninklijke InstellingSint Pieters LeeuwBelgiumParticipant
Vrije Universiteit BrusselBruxelles / BrusselBelgiumParticipant
Isansys Lifecare Europe GmbHTeltowGermanyParticipant
Siemens Healthineers AGForchheimGermanyParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Consorcio Mar Parc De Salut De BarcelonaBarcelonaSpainParticipant
Universitat Rovira I VirgiliTarragonaSpainParticipant
Institut National Polytechnique De ToulouseToulouse Cedex 4FranceParticipant
Universite De ToulouseToulouseFranceThird party
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Siemens SRLBucurestiRomaniaParticipant
Universitatea De Medicina, Farmacie, Stiinte Si Tehnologie ""george Emil Palade"" Din Targu Mures""Targu MuresRomaniaParticipant
Arrhythmia AllianceChipping NortonUnited KingdomAssociatedpartner
Liverpool Heart and Chest Hospital Nhs Foundation TrustLiverpoolUnited KingdomAssociatedpartner
Liverpool John Moores UniversityLiverpoolUnited KingdomAssociatedpartner
Liverpool University Hospital NHS Foundation TrustLiverpoolUnited KingdomAssociatedpartner
The University of LiverpoolLiverpoolUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI